FC
PGEN icon

Fore Capital’s Precigen PGEN Stock Holding History

Fore Capital’s Portfolio PGEN Stock Details PGEN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-68,500
Closed -$472K – 72
2021
Q1 		$472K Buy
+68,500
New +$579K 0.09% 54
2019
Q2 		– Sell
-20,000
Closed -$105K – 87
2019
Q1 		$105K Sell
20,000
-30,000
-60% -$208K 0.02% 59
2018
Q4 		$327K Buy
50,000
+35,000
+233% +$392K 0.16% 46
2018
Q3 		$258K Sell
15,000
-5,000
-25% -$74.4K 0.08% 48
2018
Q2 		$279K Hold
20,000
– – 0.1% 33
2018
Q1 		$307K Sell
20,000
-47,000
-70% -$672K 0.09% 53
2017
Q4 		$772K Buy
+67,000
New +$998K 0.3% 44

Other funds holding PGEN

PCM
Patient Capital Management Baltimore, Maryland $3.05B AUM 42.09% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
IAM
Iridian Asset Management Westport, Connecticut $291M AUM 49.45% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return
OCM
Occam Crest Management Darien, Connecticut $193M AUM 233.09% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return

Fore Capital's PGEN Position: Q3 2025 in Review

Fore Capital sold out of Precigen (PGEN) in Q3 2025, closing a stake of 341,811 shares — an estimated $485K sold.

Fore Capital first reported a position in PGEN in Q4 2017 and held it in 18 quarters. The position peaked at $606K in Q3 2023. 167 funds tracked by Wall St. Rank hold PGEN as of Q3 2025.

  • Fore Capital reported no remaining Precigen position as of Q3 2025 after selling out during the quarter.
  • Fore Capital sold 341,811 Precigen shares in Q3 2025, an estimated $485K.
  • Fore Capital first reported a position in Precigen in Q4 2017 and held it in 18 quarters.
  • Fore Capital's Precigen position peaked at $606K in Q3 2023.
  • 167 funds tracked by Wall St. Rank held Precigen as of Q3 2025.

Based on Fore Capital's 13F filing for Q3 2025, filed 13 Nov 2025.